The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer surveillance in adults with germline TP53 pathogenic variants: A single-center observational study.
 
Thomas Meyskens
Travel, Accommodations, Expenses - Janssen; Pfizer
 
Vincent Vandecaveye
No Relationships to Disclose
 
Steven Pans
No Relationships to Disclose
 
Raphaëla Dresen
No Relationships to Disclose
 
Chantal Van Ongeval
Research Funding - Siemens Healthineers
Travel, Accommodations, Expenses - Siemens Healthineers
 
Ann Smeets
No Relationships to Disclose
 
Ines Nevelsteen
Employment - BMSi (I); UCB (I)
Travel, Accommodations, Expenses - Roche
 
Patrick Neven
Consulting or Advisory Role - Lilly (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Radius Health (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly (Inst); Pfizer (Inst); Roche (Inst)
 
Hans Wildiers
Consulting or Advisory Role - AstraZeneca (Inst); AstraZeneca (Inst); Biocartis (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo/Lilly (Inst); Eisai (Inst); Eisai (Inst); KCE (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Novartis (Inst); Orion (Inst); Pfizer (Inst); PSI (Inst); Puma Biotechnology (Inst); Roche (Inst); Sirtex Medical (Inst)
Research Funding - Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche (Inst)
 
Patrick Schoffski
Honoraria - Blueprint Medicines; Boehringer Ingelheim; Deciphera
Consulting or Advisory Role - Adaptimmune (Inst); Advanced Medical (Inst); Blueprint Medicines; Blueprint Medicines (Inst); Boehringer Ingelheim; Deciphera; Ellipses Pharma; Ellipses Pharma (Inst); Exelixis; Guided Clarity; Intellisphere (Inst); Medscape; Transgene; Transgene (Inst); Ysios Capital
Research Funding - CoBioRes NV (Inst); Eisai (Inst); G1 Therapeutics (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Ipsen (Inst); MSD (Inst)
 
Ellen Denayer
No Relationships to Disclose
 
Griet Van Buggenhout
No Relationships to Disclose
 
Geneviève Michils
No Relationships to Disclose
 
Hilde Brems
No Relationships to Disclose
 
Eric Legius
No Relationships to Disclose
 
Kevin Punie
Honoraria - Lilly (Inst); Lilly (Inst); Mundipharma (Inst); Novartis (Inst); Pfizer; Pfizer (Inst); Pfizer (Inst); Roche (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Lilly (Inst); Lilly (Inst); Novartis; Novartis; Novartis; Novartis (Inst); Novartis (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Teva (Inst); Vifor Pharma (Inst)
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; PharmaMar; Roche; Roche; Roche; Roche